CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −3,075 | $25.30 | $78K | 17,834,725 |
| 2023-04-25 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −961 | $25.30 | $24K | 17,837,800 |
| 2023-04-24 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −66,038 | $25.42 | $1.7M | 17,838,761 |
| 2023-04-21 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −289,485 | $25.76 | $7.5M | 17,920,707 |
| 2023-04-21 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −15,908 | $26.01 | $414K | 17,904,799 |
| 2023-04-20 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −6,590 | $25.06 | $165K | 18,210,192 |
| 2023-04-19 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −76,114 | $25.12 | $1.9M | 18,216,782 |
| 2023-04-18 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −6,953 | $25.12 | $175K | 18,292,896 |
| 2023-04-17 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −10,524 | $25.06 | $264K | 18,299,849 |
| 2023-04-14 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −9,565 | $25.11 | $240K | 18,310,373 |
| 2023-04-03 | De Backer Marianne Chief Executive Officer | Grant or award | +576,452 | 576,452 | ||
| 2023-04-03 | De Backer Marianne Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,152,904 | 1,152,904 | ||
| 2023-03-30 | HANLY ANN M. Chief Technology Officer | Sale | −2,627 | $22.77 | $60K | 114,576 |
| 2023-03-27 | Lee Sung Chief Financial Officer | Grant or award | +66,500 | 66,500 | ||
| 2023-03-27 | Lee Sung Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +133,000 | 133,000 | ||
| 2023-03-08 | SATO VICKI L Director | Sale | −17,935 | $22.59 | $405K | 1,327,324 |
| 2023-03-03 | Friedl-Naderer Johanna EVP & Chief Operating Officer | Sale | −1,482 | $22.82 | $34K | 148,518 |
| 2023-03-01 | Sigal Charles Elliott Director | Purchase | +2,500 | $22.73 | $57K | 10,000 |
| 2023-02-27 | Pang Phillip Chief Medical Officer | Sale | −8,920 | $23.00 | $205K | 189,400 |
| 2023-02-27 | Pang Phillip Chief Medical Officer | Sale | −1,400 | $23.56 | $33K | 188,000 |
Page 14 of 54 · 1,063 trades